JRI is changing shareholders to accelerate its development and strengthen its leadership in wireless traceability and metrological monitoring solutions and metrology services. The management team led by Pascal Vermeersch (former executive and investor in service SMEs) associated with JRI's current management team (composed of Eric Cartalas and André Grezel) and Turenne Santé are leading the takeover of JRI with a round table that also includes Bpifrance and InnovaFonds.
The JRI Group designs and manufactures monitoring systems for various parameters (temperature, humidity, pressure, CO2...) to meet the legal provisions for traceability for the health and agri-food sectors. Its solutions are based on B to B connected objects, driven from software installed at the customer's home or in Saas mode, which perform remote controls.
The JRI Group also offers its clients a range of metrology services (calibration, calibration, mapping, qualification...) and has numerous Cofrac accreditations.
The development plan requires an ambitious strategy that includes:
- The development of activities with pharmaceutical companies;
- The deployment of new solutions in the field of transport;
- Expanding the range of B to B connected objects and Saas solutions;
- Establishing partnerships with specialized distributors to accelerate international growth.
Pascal Vermeersch, President of JRI, said: "JRI is a solid company, a true French reference in surveillance and traceability in the health and agri-food sectors. Thanks to our capacity for innovation and the support of our financial partners, we will be able to continue our development and international expansion."
Eric Cartalas, JRI's Deputy General Manager of Sales and Operations, said: "Our goal is to accelerate the development of our maintenance and metrology services by building on our understanding of our customers' needs and to implement our Saas solutions in China, the USA, Latin America and the Middle East."
André Grezel, JRI's technical and quality director, said: "The arrival of new shareholders will allow us to accelerate our ability to innovate in radiofrequency, the Internet of Things and of course metrology in order to maintain our technological leadership."
Mounia Chaoui, associate director of Turenne Santé, adds: "JRI is at the crossroads of two evolving markets, health and connected objects. There are many development opportunities and we are confident in the ability of management to seize them. This transaction is fully in line with Turenne Santé's investment strategy to support the transmission of growing businesses in the Healthcare Industry."
Cyril Chaumien, director of equity at Bpifrance, concludes: "We are happy to support the transmission of a beautiful company while giving it the means to continue to innovate in its market, in order to grow in France and internationally."
Find out more: www.jri.fr